Astellas Turns to AAV-based Gene Therapy with Taysha Gene Therapies Collaboration Deal
By Ashish Tripathi
Pharma Deals Review: Vol 2022 Issue 11 (Table of Contents)
Published: 9 Nov-2022
DOI: 10.3833/pdr.v2022.i11.2746 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In a bid to bolster its neurology pipeline, Astellas has entered into a collaboration agreement with Taysha Gene Therapies in a deal worth up to US$50 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018